The Brain-Gut Health Initiative has mapped comprehensive brain-gut-microbiome interactions across over 1,200 participants with schizophrenia, major depression, and bipolar disorder using neuroimaging, EEG, blood biomarkers, and gut microbiome sequencing. The cohort reveals systematic relationships linking brain function, peripheral markers, and microbial profiles, with marked individual variation in these networks. This represents a paradigm shift toward understanding psychiatric disorders through the microbiota-gut-brain axis rather than isolated brain pathology. The longitudinal design enables tracking how these interconnected systems evolve over time, potentially identifying early biomarkers or intervention targets. While previous research has suggested gut-brain connections in mental health, this scale of multimodal data collection in psychiatric populations is unprecedented. The heterogeneity findings are particularly significant—they suggest personalized medicine approaches may be essential rather than one-size-fits-all treatments. However, the study's immediate clinical applications remain unclear, and validation across different populations will be critical. This work positions the gut microbiome as a legitimate therapeutic frontier in psychiatry, potentially opening pathways for microbiome-targeted interventions alongside traditional psychiatric treatments.